文献速递甲状腺疾病

淋巴结检出数目与甲状腺乳头状癌侧颈转移患者肿瘤结局的关联

The Association of Number of Retrieved Lymph Nodes with Oncologic Outcomes in Patients with Papillary Thyroid Cancer with Lateral Cervical Nodal Metastasis.
PubMed 文献 · Thyroid · 2025-10-15

该回顾性队列纳入1003例伴侧颈淋巴结转移(N1b)的甲状腺乳头状癌患者,均行侧颈淋巴结清扫,按淋巴结检出总数分组分析其与复发及癌特异性死亡的关系。中位随访90.0个月,检出淋巴结总数越高,复发与癌特异性死亡的调整风险越低;与最低癌特异性死亡风险对应的检出数约为32–33枚。

要点

  • N1b期PTC患者淋巴结检出总数与复发和癌特异性死亡呈负相关
  • 检出总数≥33枚组复发aHR 0.51(0.35–0.73),癌特异性死亡aHR 0.14(0.04–0.47)
  • 检出淋巴结总数或可作为PTC颈淋巴结清扫的质量指标

核心结论

  • 在伴侧颈淋巴结转移的PTC患者中,淋巴结检出总数与复发及癌特异性死亡相关,结局在约32–33枚时似乎更佳,提示其可能作为颈淋巴结清扫的质量指标。

研究设计与样本

  • 回顾性队列研究,纳入1003例伴N1b期病变且行侧颈淋巴结清扫的甲状腺乳头状癌患者,按淋巴结检出总数分类。
  • 采用多因素Cox比例风险模型分析复发与癌特异性死亡,并用限制性立方样条分析确定最佳检出淋巴结数。

主要发现

  • 初次手术时淋巴结检出总数中位数为36.0(25.0–49.0)枚,阳性淋巴结数中位数为9.0(5.0–14.0)枚。
  • 中位随访90.0(73.0–129.0)个月期间,165例复发、30例癌特异性死亡。
  • 淋巴结检出总数越高,复发调整风险比分别为0.50、0.51、0.33、0.28(趋势P=0.001),癌特异性死亡分别为0.33、0.13、0.02、0.04(趋势P=0.002)。

关键数值与推荐

  • 与最低复发率和癌特异性死亡对应的估计淋巴结检出总数分别为32枚和33枚。

临床怎么用

  • 对伴侧颈淋巴结转移的PTC患者行颈淋巴结清扫时,可关注淋巴结检出总数是否达到约33枚,以评估清扫质量并辅助风险分层。

局限性

  • 本研究为回顾性设计,结论主要适用于侵袭性较强的病例,仍需前瞻性研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The number of retrieved lymph nodes (rLN) is an important surgical metric associated with survival in cancer. However, its association with oncological outcomes in patients with papillary thyroid cancer (PTC) with lateral lymph node (LN) metastasis (N1b disease) has not been investigated. Methods: This retrospective cohort study included patients with PTC and N1b disease (N = 1003) who underwent lateral neck dissection and categorized them by total number of rLNs. We investigated the association of the categories with recurrence or cancer-specific mortality (CSM) using multivariable Cox proportional hazard models. The optimal number of rLNs associated with low recurrence rate or CSM were identified using restricted cubic spline analysis. Survival analyses across subgroups were performed according to adequate (the estimated total number of rLN at which CSM appeared to be lowest) and inadequate groups. Results: At initial surgery, the median total number of rLNs and positive number of LNs was 36.0 (25.0-49.0) and 9.0 (5.0-14.0), respectively. During a median follow-up of 90.0 (73.0-129.0) months, recurrence and CSM were detected in 165 and 30 patients, respectively. A higher total number of rLNs was inversely associated with the adjusted hazard ratio (aHR) for recurrence (0.50, 0.51, 0.33, and 0.28; p for trend = 0.001) and CSM (0.33, 0.13, 0.02, and 0.04; p for trend 0.002). The estimated total number of rLNs associated with the lowest recurrence rate and CSM were 32 and 33, respectively. Compared with the inadequate rLNs group, the adequate rLNs group (≥33 total rLNs) showed better prognosis in the entire group (aHR 0.51 [0.35-0.73], p < 0.001; recurrence) (aHR 0.14 [0.04-0.47], p = 0.001; CSM) and various subgroups. Conclusions: rLNs are associated with recurrence and CSM in patients with PTC and N1b disease, with outcomes appearing to improve at approximately 32-33. This finding suggests that rLNs may serve as a potential quality indicator for neck dissection in PTC. Our finding is mostly applicable to more aggressive disease, and further prospective confirmatory research is warranted.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Kim HI, Shin JH, Kim B, et al. The Association of Number of Retrieved Lymph Nodes with Oncologic Outcomes in Patients with Papillary Thyroid Cancer with Lateral Cervical Nodal Metastasis. Thyroid. 2025. PMID: 41167632. doi:10.1177/10507256251388093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。